Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CluePoints Appoints Usama Dar Chief Product & Technology Officer
Breaking News, Promotions & Moves

CluePoints Appoints Usama Dar as Chief Product and Technology Officer

Dar has served in leadership roles at Westwing, Sciensus, Elsevier, The Guardian, and Huawei.

CluePoints, a provider of statistical and AI-driven software solutions, appointed Usama Dar as its new Chief Product and Technology Officer. Having led both product and R&D teams through significant expansion, Dar is positioned to help CluePoints in the next phase of growth.

Andy Cooper, CEO at CluePoints, commented: “CluePoints has gone from being a very successful single-product company to a multi-product company undergoing a period of rapid growth, both in terms of people and our platform. Usama is the perfect fit to support us on our journey to provide the most comprehensive, and highest quality, Integrated Data Review platform for the Clinical Development industry.”

Dar has worked in leadership roles at Westwing, Sciensus, Elsevier, The Guardian, and Huawei. With a career spanning eCommerce, SaaS, and AI, he has experience building and leading teams.

“What attracted me to CluePoints was its mission to harness technology to improve and accelerate clinical trials, the people working within the organization, and the difference I can make,” Dar said. “I look forward to using my extensive engineering experience and product background to streamline product development, scale CluePoints’ offering, and take it to the next level.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters